BD (NYSE:BDX) announced Thursday that the company has increased its domestic manufacturing of syringes after the FDA warned about quality issues linked to plastic syringes made in China. Since the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results